A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Clinical trial NCT07003542 · RECRUITING
Trial details
- NCT number
- NCT07003542
- Sponsor
- Case Comprehensive Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2027-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.